The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa
- PMID: 11386493
- DOI: 10.1097/00004714-200106000-00008
The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa
Abstract
A randomized, placebo-controlled study was conducted examining the singular and combined effects of fluoxetine and a self-help manual on suppressing bulimic behaviors in women with bulimia nervosa. A total of 91 adult women with bulimia nervosa were randomly assigned to one of four conditions: placebo only, fluoxetine only, placebo and a self-help manual, or fluoxetine and a self-help manual. Subjects were treated for 16 weeks. Primary outcome measures included self-reports of bulimic behaviors. Fluoxetine and a self-help manual were found to be effective in reducing the frequency of vomiting episodes and in improving the response rates for vomiting and binge-eating episodes. Furthermore, both factors were shown to be acting additively on the primary and secondary efficacy measures in this study. Results are discussed in relation to previous research and the implications for treatment of bulimia nervosa.
Similar articles
-
Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression.Int J Eat Disord. 1999 Jan;25(1):19-27. doi: 10.1002/(sici)1098-108x(199901)25:1<19::aid-eat3>3.0.co;2-3. Int J Eat Disord. 1999. PMID: 9924649 Clinical Trial.
-
A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.Am J Psychiatry. 2002 Jan;159(1):96-102. doi: 10.1176/appi.ajp.159.1.96. Am J Psychiatry. 2002. PMID: 11772696 Clinical Trial.
-
An open trial of fluoxetine for adolescents with bulimia nervosa.J Child Adolesc Psychopharmacol. 2003 Fall;13(3):329-35. doi: 10.1089/104454603322572660. J Child Adolesc Psychopharmacol. 2003. PMID: 14642021 Clinical Trial.
-
Efficacy of pharmacotherapies for bulimia nervosa: a systematic review and meta-analysis.BMC Pharmacol Toxicol. 2023 Dec 2;24(1):72. doi: 10.1186/s40360-023-00713-7. BMC Pharmacol Toxicol. 2023. PMID: 38042827 Free PMC article.
-
[Psychopharmacologic treatment of bulimia nervosa].Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1993 Nov-Dec;21(6):211-20. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1993. PMID: 8172007 Review. Spanish.
Cited by
-
Psychological treatments for bulimia nervosa and binging.Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD000562. doi: 10.1002/14651858.CD000562.pub3. Cochrane Database Syst Rev. 2009. PMID: 19821271 Free PMC article.
-
Internet-based aftercare for women with bulimia nervosa following inpatient treatment: The role of adherence.Internet Interv. 2019 Jan 14;15:67-75. doi: 10.1016/j.invent.2018.11.004. eCollection 2019 Mar. Internet Interv. 2019. PMID: 30723692 Free PMC article.
-
Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions.Curr Psychiatry Rep. 2016 Jun;18(6):55. doi: 10.1007/s11920-016-0696-z. Curr Psychiatry Rep. 2016. PMID: 27086316 Review.
-
Current and emerging directions in the treatment of eating disorders.Subst Abuse. 2012;6:33-61. doi: 10.4137/SART.S7864. Epub 2012 Mar 29. Subst Abuse. 2012. PMID: 22879753 Free PMC article.
-
Antidepressants versus placebo for people with bulimia nervosa.Cochrane Database Syst Rev. 2001;2003(4):CD003391. doi: 10.1002/14651858.CD003391. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2003;(4):CD003391. doi: 10.1002/14651858.CD003391. PMID: 11687198 Free PMC article. Updated.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources